PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
13-Jan-2022 Bridging Scotland’s skills gap in Advanced Therapies Edinburgh Napier University
13-Jan-2022 Eagle Genomics and Quadram Institute’s New Strategic Partnership to Accelerate Microbiome Analysis Through AI-Augmented Knowledge Discovery Platform Eagle Genomics
13-Jan-2022 AstraZeneca and Scorpion Therapeutics enter agreement to discover, develop and commercialise novel cancer treatments against ‘undruggable’ targets AstraZeneca
13-Jan-2022 EISAI TO LAUNCH DIGITAL TOOL “CogMate™” IN TAIWAN AND HONG KONG FOR SELF-ASSESSMENT OF BRAIN PERFORMANCE (BRAIN HEALTH) EISAI
13-Jan-2022 Eagle Genomics and Quadram Institute’s New Strategic Partnership to Accelerate Microbiome Analysis Through AI-Augmented Knowledge Discovery Platform B3C newswire
13-Jan-2022 Abivax receives EMA Scientific Advice supportive of moving ABX464 into phase 3 clinical testing in ulcerative colitis ABIVAX
12-Jan-2022 atai Life Sciences announces FDA Investigational New Drug (IND) Clearance for PCN-101 R-ketamine Program atai Life Sciences
12-Jan-2022 HUTCHMED Receives Breakthrough Therapy Designation in China for HMPL-523 for Treatment of Primary Immune Thrombocytopenia HUTCHMED
12-Jan-2022 ProBioGen Announces Innovent as a New Partner Signing License of GlymaxX® Technology ProBioGen
12-Jan-2022 Pharma time-to-market reduced thanks to more efficient submission document publishing services PharmaLex
12-Jan-2022 Rousselot Announces Partnership with Terasaki Institute for Biomedical Innovation Rousselot
12-Jan-2022 Apposite Capital-backed Kelso Pharma acquires Stirling Anglian Pharmaceuticals Apposite Capital
12-Jan-2022 Calibre Scientific Acquires BrightBox Quantitation, A US Reagent Manufacturer Specializing in NGS Library Quantitation Calibre Scientific
12-Jan-2022 Envirotainer welcomes Delta Cargo as the latest airline to approve the new Releye® RLP container Envirotainer
12-Jan-2022 European Commission Approves KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in Combination With Ivacaftor to Treat Children With Cystic Fibrosis Ages 6 to 11 Years Vertex Pharmaceuticals Incorporated
12-Jan-2022 SaniSure Announces the Acquisition of GL Engineering to Globally Expand its Drug Product Fill and Finish Solutions SaniSure
12-Jan-2022 Idorsia receives US FDA approval of QUVIVIQ (daridorexant) 25 and 50 mg for the treatment of adults with insomnia Idorsia Ltd
12-Jan-2022 GROWTH OF PHARMACEUTICAL AND LIFE SCIENCES MARKET LEADS TO EXCITING ACQUISITION FOR WORKPLACE STRATEGY, DESIGN AND CONSTRUCTION FIRM Unispace
12-Jan-2022 MODERNA ANNOUNCES ADVANCES ACROSS ITS INDUSTRY-LEADING MRNA PIPELINE AND PROVIDES BUSINESS UPDATE Moderna, Inc.
12-Jan-2022 Tiziana Enrolls Second Patient in Ongoing Intranasal Foralumab Evaluation for Secondary Progressive Multiple Sclerosis Tiziana Life Sciences